|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CSD00197 |
| 保存条件 | store at -80℃ |
| 用途 | 仅用于科研用途 |
| 应用范围 | |
| 抗原来源 | CHO cells |
| CAS编号 | 955085-14-0 |
| 保质期 | 一年 |
| 抗体名 | Solanezumab ( 苏兰组单抗 ) |
| 是否单克隆 | |
| 克隆性 | |
| 靶点 | APP Abeta,soluble monomer[Homo sapiens] |
| 适应物种 | |
| 形态 | |
| 宿主 | |
| 标记物 | |
| 包装规格 | 1mg/ml |
| 纯度 | % |
| 亚型 | |
| 标识物 | |
| 浓度 | 95% |
| 免疫原 | |
| 是否进口 | 否 |
Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
货号（Catalog No.）
CSD00197
通用名INN
Solanezumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
别名(Alternative names)
LY2062430
靶点;物种(Specificity target name;species)
APP Abeta,soluble monomer[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
955085-14-0
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
